How many stroke survivors develop problematic spasticity requiring pharmacological therapy? An international (Europe and USA) observational study protocol
Introduction Current care plans for stroke survivors typically focus on acute management, resulting in many stroke survivors being discharged to their communities without adequate follow-up, despite their often experiencing significant post-stroke complications, such as post-stroke spasticity (PSS)....
Saved in:
Main Authors: | Pascal Maisonobe, Sergiu Groppa, Simon Page, Richard D Zorowitz, Laura Serrano Barrenechea, Simon Butet, David Hernández Herrero, Rama Prasad, Susan Sandars, Seema Meloni, Alessandro Picelli |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2025-01-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/15/1/e087404.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Muscle selection and dosing in patients undergoing treatment with abobotulinumtoxinA for lower limb spasticity in real-world practice
by: Richard D. Zorowitz, et al.
Published: (2025-02-01) -
Functional Brain Correlates of Upper Limb Spasticity and Its Mitigation following Rehabilitation in Chronic Stroke Survivors
by: Svetlana Pundik, et al.
Published: (2014-01-01) -
Selective posterior rhizotomy for the treatment of pure hereditary spastic paraplegia⁃ associated lower limb spasticity
by: TANG Nan, et al.
Published: (2024-12-01) -
Esophageal Motility Testing: The Spastic Truth
by: William Paterson, et al.
Published: (2007-01-01) -
Problematic textual sums on economics
by: Vaclovas Viruišis
Published: (2002-12-01)